Cabot Corporation $CBT Shares Acquired by William Blair Investment Management LLC

William Blair Investment Management LLC raised its stake in shares of Cabot Corporation (NYSE:CBT – Free Report) by 19.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 220,897 shares of the specialty chemicals company’s stock after buying an additional 35,820 shares during the quarter. William Blair Investment Management LLC’s holdings in Cabot were worth $16,989,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of CBT. BlackRock Inc. purchased a new position in shares of Cabot in the second quarter worth $633,302,000. State Street Corp grew its stake in Cabot by 6.8% during the second quarter. State Street Corp now owns 2,165,434 shares of the specialty chemicals company’s stock valued at $196,665,000 after acquiring an additional 138,098 shares in the last quarter. Bank of America Corp DE purchased a new position in Cabot during the second quarter valued at $150,772,000. Dimensional Fund Advisors LP increased its holdings in Cabot by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock valued at $131,253,000 after acquiring an additional 79,499 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in Cabot by 6.5% in the 1st quarter. Sei Investments Co. now owns 1,051,578 shares of the specialty chemicals company’s stock valued at $79,194,000 after acquiring an additional 64,122 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Trading Up 0.1%

CBT stock opened at $71.99 on Monday. The firm has a fifty day moving average price of $75.86 and a 200 day moving average price of $79.54. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The firm has a market cap of $3.72 billion, a PE ratio of 17.95, a price-to-earnings-growth ratio of 9.11 and a beta of 0.83. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.44 and a current ratio of 2.16.

Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.06. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $927.29 million. Cabot had a net margin of 5.69% and a return on equity of 19.64%. Cabot’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.70 earnings per share. Sell-side analysts anticipate that Cabot Corporation will post 6.58 earnings per share for the current fiscal year.

Insider Activity at Cabot

In other Cabot news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 3.08% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts have commented on CBT shares. Weiss Ratings cut shares of Cabot from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $78.00 to $68.00 and set an “underweight” rating for the company in a report on Tuesday, November 10th. UBS Group cut their price objective on Cabot from $86.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Truist Financial reduced their target price on Cabot from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Finally, Zacks Research downgraded Cabot from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 5th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus price target of $83.60.

Get Our Latest Report on CBT

Cabot Profile

(Free Report)

Cabot Corporation is a specialty chemicals and performance materials company that develops and manufactures materials used in products across transportation, energy, infrastructure, electronics and consumer markets. Its offerings include reinforcing carbon blacks for tires and other rubber products, specialty carbons and battery materials, fumed silica and other specialty compounds. Founded in 1882, Cabot has expanded from its early carbon black business into a broader portfolio of performance materials.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.